Chiasma, Inc. (NASDAQ:CHMA) Worth a Look

By HEFFX Australia on June 26, 2020   2020, Headline News, Health, Heffx Insights, Investments, Shayne Heffernan, Shayne Heffernan, Stocks  

Chiasma, Inc. (NASDAQ:CHMA) $CHMA #Stocks #Pharmaceuticals Worth a Look Chiasma is a clinical, late-stage biopharmaceutical company ChiasmaTicker: NASDAQ:CHMAPrice: $6.57Recommendation: Buy Company News Today the FDA is also expected to rule on Chiasma Inc’s (NASDAQ: CHMA) NDA for Mycapssa, which is being evaluated as a maintenance therapy for acromegaly. Business Summary Chiasma, Inc. is a biopharmaceutical company. The Company […]